Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03573804 · ClinicalTrials.gov registry record · NA
The Prone to Supine Breast MRI Trial
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 72
- Enrollment target
NCT03573804 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 72 participants.
The verdict
NCT03573804, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a supine MRI obtained immediately after a standard diagnostic prone MRI exam, without a second injection of gadolinium (Gd) contrast material, would be of sufficient quality to allow the Radiologist to define the tumor edges ("segment" the tumor) so that a 3-D image of the tumor can be generated to form a BCL.
Interventions
- OTHER Prone to Supine MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2018-07-12 |
| Est. Completion | 2020-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03573804
The ClinicalTrials.gov registry entry for NCT03573804 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prone to Supine MRI is the first listed.
NCT03573804 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03573804 about?
NCT03573804 is a clinical study titled "The Prone to Supine Breast MRI Trial". The purpose of this study is to determine whether a supine MRI obtained immediately after a standard diagnostic prone MRI exam, without a second injection of gadolinium (Gd) contrast material, would be of sufficient quality to allow the Radiologist to define the tumor edges ("segment" the tumor) so ...
What is the current status of trial NCT03573804?
This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2018-07-12. Estimated completion is 2020-07-31.
What interventions are being tested in trial NCT03573804?
The interventions under investigation include: Prone to Supine MRI (OTHER).
Who is sponsoring clinical trial NCT03573804?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.